Cas 524019-35-0,8-[Bis(2-chlorophenyl)methyl]-3-(1-methyl-1H-indol-2-yl)-8-azabicyclo[3.2.1]octan-3-ol

524019-35-0

Post Buying Request

Basic information

Product Name: 8-[Bis(2-chlorophenyl)methyl]-3-(1-methyl-1H-indol-2-yl)-8-azabicyclo[3.2.1]octan-3-ol
Synonyms:
CAS NO:524019-35-0
Molecular Formula:
Molecular Weight: 491.46
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 8-[Bis(2-chlorophenyl)methyl]-3-(1-methyl-1H-indol-2-yl)-8-azabicyclo[3.2.1]octan-3-ol(CAS DataBase Reference)
NIST Chemistry Reference: 8-[Bis(2-chlorophenyl)methyl]-3-(1-methyl-1H-indol-2-yl)-8-azabicyclo[3.2.1]octan-3-ol(524019-35-0)
EPA Substance Registry System: 8-[Bis(2-chlorophenyl)methyl]-3-(1-methyl-1H-indol-2-yl)-8-azabicyclo[3.2.1]octan-3-ol(524019-35-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 524019-35-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

524019-35-0 Suppliers

Recommended suppliers

524019-35-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 524019-35-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,2,4,0,1 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 524019-35:
(8*5)+(7*2)+(6*4)+(5*0)+(4*1)+(3*9)+(2*3)+(1*5)=120
120 % 10 = 0
So 524019-35-0 is a valid CAS Registry Number.

524019-35-0Upstream product

524019-35-0Downstream Products

524019-35-0Relevant academic research and scientific papers

Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1

-

, (2008/06/13)

Novel compounds of the formula wherein R is optionally substituted heteroaryl or R1 is H or C1—C6 alkyl; and R2 and R3 are —CH3, —OCH3 or halo; or a pharmaceutically acceptable salt or solvate thereof, pharmaceutical compositions therefore, and the use of said compounds in the treatment of pain, anxiety, cough, asthma, depression and alcohol abuse are disclosed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 524019-35-0